133 related articles for article (PubMed ID: 25535872)
1. Fascin expression is increased in metastatic lesions but does not correlate with progression nor outcome in melanoma.
Ma Y; Faller WJ; Sansom OJ; Brown ER; Doig TN; Melton DW; Machesky LM
Melanoma Res; 2015 Apr; 25(2):169-72. PubMed ID: 25535872
[TBL] [Abstract][Full Text] [Related]
2. Fascin expression in melanocytic lesions of the skin.
YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
[TBL] [Abstract][Full Text] [Related]
3. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
[TBL] [Abstract][Full Text] [Related]
6. Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
Min KW; Kim DH; Do SI; Chae SW; Kim K; Sohn JH; Pyo JS; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kim EK; Kwon MJ; Seo J; Moon KM
Virchows Arch; 2016 Apr; 468(4):409-16. PubMed ID: 26719157
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
[TBL] [Abstract][Full Text] [Related]
8. Fascin expression is related to poor survival in gastric cancer.
Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
[TBL] [Abstract][Full Text] [Related]
9. The prognostic relevance of fascin expression in human gastric carcinoma.
Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
[TBL] [Abstract][Full Text] [Related]
10. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer.
Pelosi G; Pastorino U; Pasini F; Maissoneuve P; Fraggetta F; Iannucci A; Sonzogni A; De Manzoni G; Terzi A; Durante E; Bresaola E; Pezzella F; Viale G
Br J Cancer; 2003 Feb; 88(4):537-47. PubMed ID: 12592367
[TBL] [Abstract][Full Text] [Related]
11. Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis.
Tan VY; Lewis SJ; Adams JC; Martin RM
BMC Med; 2013 Feb; 11():52. PubMed ID: 23442983
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
13. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
14. Melanoma prognostic model using tissue microarrays and genetic algorithms.
Gould Rothberg BE; Berger AJ; Molinaro AM; Subtil A; Krauthammer MO; Camp RL; Bradley WR; Ariyan S; Kluger HM; Rimm DL
J Clin Oncol; 2009 Dec; 27(34):5772-80. PubMed ID: 19884546
[TBL] [Abstract][Full Text] [Related]
15. Fascin expression predicts lymph node metastasis and worse survival in small intestinal carcinoma.
Gu MJ; Kim JY; Park JB
Pathology; 2014 Jan; 46(1):21-4. PubMed ID: 24300716
[TBL] [Abstract][Full Text] [Related]
16. Novel role for RGS1 in melanoma progression.
Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
[TBL] [Abstract][Full Text] [Related]
17. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
[TBL] [Abstract][Full Text] [Related]
18. Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma.
Stewart CJ; Crook ML
Hum Pathol; 2015 Oct; 46(10):1514-20. PubMed ID: 26239622
[TBL] [Abstract][Full Text] [Related]
19. Maspin expression and melanoma progression: a matter of sub-cellular localization.
Martinoli C; Gandini S; Luise C; Mazzarol G; Confalonieri S; Giuseppe Pelicci P; Testori A; Ferrucci PF
Mod Pathol; 2014 Mar; 27(3):412-9. PubMed ID: 24030740
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma.
Gun BD; Bahadir B; Bektas S; Barut F; Yurdakan G; Kandemir NO; Ozdamar SO
Diagn Pathol; 2012 Jul; 7():80. PubMed ID: 22784357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
